Tourmaline Bio, Inc.

NasdaqGS:TRML Stock Report

Market Cap: US$353.2m

Tourmaline Bio Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:TRML Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
29 Jan 24BuyUS$3,250,000Qiming Weichuang Venture Capital Management (Shanghai) Company LimitedCompany100,000US$32.50
17 Nov 23BuyUS$67,960Sandeep KulkarniIndividual4,000US$16.99
17 Nov 23BuyUS$17,310Parvinder ThiaraIndividual1,000US$17.31
27 Oct 23BuyUS$280,584Caley CasteleinIndividual20,000US$14.55
26 Oct 23BuyUS$110,912Sandeep KulkarniIndividual9,650US$12.25
25 Oct 23BuyUS$77,540Parvinder ThiaraIndividual7,000US$12.12
24 Oct 23BuyUS$88,950Aaron KantoffIndividual7,500US$11.86

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of TRML?
Owner TypeNumber of SharesOwnership Percentage
Public Companies1,272,2144.89%
Private Companies1,703,5726.54%
Individual Insiders2,166,4948.32%
Hedge Funds2,222,2228.53%
VC/PE Firms4,520,39417.4%
Institutions14,155,01754.4%

Dilution of Shares: TRML only recently listed within the past 12 months


Top Shareholders

Top 25 shareholders own 86.19% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.66%
Avoro Capital Advisors LLC
2,222,222US$30.6m156%0.39%
6.64%
Hydra Llc
1,702,164US$23.4m0%no data
6.22%
Deep Track Capital, LP
1,595,400US$22.0m-12.1%0.64%
5.76%
TCG Crossover Management, LLC
1,477,593US$20.3m46.6%1.76%
5.64%
CHI Advisors LLC
1,447,401US$19.9m8.64%6.78%
4.96%
Pfizer Inc.
1,272,214US$17.5m0%no data
4.87%
Cormorant Asset Management, LP
1,250,000US$17.2m0%0.94%
4.35%
Jennison Associates LLC
1,115,251US$15.4m0%0.01%
3.8%
Caley Castelein
974,558US$13.4m0%no data
3.7%
QVT Financial LP
948,366US$13.1m0%0.82%
3.57%
The Vanguard Group, Inc.
914,519US$12.6m19.7%no data
3.54%
Braidwell LP
906,820US$12.5m0%0.76%
2.89%
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited
741,691US$10.2m0%1.13%
2.89%
RTW Investments, LP
741,656US$10.2m86%0.17%
2.85%
Sandeep Kulkarni
729,735US$10.0m0%no data
2.73%
Nantahala Capital Management, LLC
700,907US$9.7m70.6%0.97%
2.31%
Vivo Capital, LLC
591,882US$8.2m0%0.7%
1.93%
BlackRock, Inc.
495,375US$6.8m81.9%no data
1.81%
Darwin Global Management Limited
465,000US$6.4m0%1.11%
1.26%
Longitude Capital Management Co., LLC
322,077US$4.4m0%0.99%
1.25%
Eventide Asset Management, LLC
320,916US$4.4m0%0.07%
1.24%
Velan Capital Partners LP
319,080US$4.4m0%2.65%
1.23%
Artal Group S.A.
314,496US$4.3m244%0.1%
1.07%
StemPoint Capital LP
274,219US$3.8m0%1.13%
1.02%
Acuta Capital Partners, LLC
261,108US$3.6m12.6%2.77%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.